Acute pancreatitis caused by bortezomib. 2013

Tevfik Solakoglu, and Pinar Akyol, and Tekin Guney, and Imdat Dilek, and Roni Atalay, and Huseyin Koseoglu, and Ebru Akin, and Aylin Demirezer Bolat, and Naciye Semnur Buyukasik, and Osman Ersoy
Department of Gastroenterology, Ankara Ataturk Research and Education Hospital, Bilkent Street, 06800 Ankara, Turkey. tfksolak@yahoo.com.tr

Drug-induced pancreatitis has been reported rarely. Bortezomib is a selective and reversible proteasome inhibitor used for the treatment of patients with multiple myeloma (MM). Recently, one case report about acute pancreatitis (AP) caused by bortezomib was published in the international literature. Herein we report a case of AP in a 67-year-old male on bortezomib therapy. On the fourth day after the first administration of bortezomib, the patient admitted to the hospital with symptoms of AP. The common etiological factors for AP were all excluded. Than the patient was diagnosed as bortezomib-induced pancreatitis.

UI MeSH Term Description Entries
D008297 Male Males
D009101 Multiple Myeloma A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY. Myeloma, Plasma-Cell,Kahler Disease,Myeloma, Multiple,Myeloma-Multiple,Myelomatosis,Plasma Cell Myeloma,Cell Myeloma, Plasma,Cell Myelomas, Plasma,Disease, Kahler,Multiple Myelomas,Myeloma Multiple,Myeloma, Plasma Cell,Myeloma-Multiples,Myelomas, Multiple,Myelomas, Plasma Cell,Myelomas, Plasma-Cell,Myelomatoses,Plasma Cell Myelomas,Plasma-Cell Myeloma,Plasma-Cell Myelomas
D010195 Pancreatitis INFLAMMATION of the PANCREAS. Pancreatitis is classified as acute unless there are computed tomographic or endoscopic retrograde cholangiopancreatographic findings of CHRONIC PANCREATITIS (International Symposium on Acute Pancreatitis, Atlanta, 1992). The two most common forms of acute pancreatitis are ALCOHOLIC PANCREATITIS and gallstone pancreatitis. Acute Edematous Pancreatitis,Acute Pancreatitis,Pancreatic Parenchyma with Edema,Pancreatic Parenchymal Edema,Pancreatitis, Acute,Pancreatitis, Acute Edematous,Peripancreatic Fat Necrosis,Acute Edematous Pancreatitides,Acute Pancreatitides,Edema, Pancreatic Parenchymal,Edematous Pancreatitides, Acute,Edematous Pancreatitis, Acute,Fat Necrosis, Peripancreatic,Necrosis, Peripancreatic Fat,Pancreatic Parenchymal Edemas,Pancreatitides, Acute,Pancreatitides, Acute Edematous,Parenchymal Edema, Pancreatic,Peripancreatic Fat Necroses
D011719 Pyrazines A heterocyclic aromatic organic compound with the chemical formula C4H4N2. Pyrazine
D001897 Boronic Acids Inorganic or organic compounds that contain the basic structure RB(OH)2. Boronic Acid,Acid, Boronic,Acids, Boronic
D003907 Dexamethasone An anti-inflammatory 9-fluoro-glucocorticoid. Hexadecadrol,Decaject,Decaject-L.A.,Decameth,Decaspray,Dexasone,Dexpak,Hexadrol,Maxidex,Methylfluorprednisolone,Millicorten,Oradexon,Decaject L.A.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000069286 Bortezomib A pyrazine and boronic acid derivative that functions as a reversible PROTEASOME INHIBITOR. It is used as an ANTINEOPLASTIC AGENT in the treatment of MULTIPLE MYELOMA and MANTLE CELL LYMPHOMA. LDP-341,PS 341,PS-341,Velcade,341, PS,LDP 341,LDP341,PS341
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy

Related Publications

Tevfik Solakoglu, and Pinar Akyol, and Tekin Guney, and Imdat Dilek, and Roni Atalay, and Huseyin Koseoglu, and Ebru Akin, and Aylin Demirezer Bolat, and Naciye Semnur Buyukasik, and Osman Ersoy
May 2010, JOP : Journal of the pancreas,
Tevfik Solakoglu, and Pinar Akyol, and Tekin Guney, and Imdat Dilek, and Roni Atalay, and Huseyin Koseoglu, and Ebru Akin, and Aylin Demirezer Bolat, and Naciye Semnur Buyukasik, and Osman Ersoy
June 2020, Cureus,
Tevfik Solakoglu, and Pinar Akyol, and Tekin Guney, and Imdat Dilek, and Roni Atalay, and Huseyin Koseoglu, and Ebru Akin, and Aylin Demirezer Bolat, and Naciye Semnur Buyukasik, and Osman Ersoy
April 1989, Revista clinica espanola,
Tevfik Solakoglu, and Pinar Akyol, and Tekin Guney, and Imdat Dilek, and Roni Atalay, and Huseyin Koseoglu, and Ebru Akin, and Aylin Demirezer Bolat, and Naciye Semnur Buyukasik, and Osman Ersoy
August 1954, Khirurgiia,
Tevfik Solakoglu, and Pinar Akyol, and Tekin Guney, and Imdat Dilek, and Roni Atalay, and Huseyin Koseoglu, and Ebru Akin, and Aylin Demirezer Bolat, and Naciye Semnur Buyukasik, and Osman Ersoy
October 2004, European journal of emergency medicine : official journal of the European Society for Emergency Medicine,
Tevfik Solakoglu, and Pinar Akyol, and Tekin Guney, and Imdat Dilek, and Roni Atalay, and Huseyin Koseoglu, and Ebru Akin, and Aylin Demirezer Bolat, and Naciye Semnur Buyukasik, and Osman Ersoy
July 2001, Anales de medicina interna (Madrid, Spain : 1984),
Tevfik Solakoglu, and Pinar Akyol, and Tekin Guney, and Imdat Dilek, and Roni Atalay, and Huseyin Koseoglu, and Ebru Akin, and Aylin Demirezer Bolat, and Naciye Semnur Buyukasik, and Osman Ersoy
April 2014, Gastrointestinal endoscopy,
Tevfik Solakoglu, and Pinar Akyol, and Tekin Guney, and Imdat Dilek, and Roni Atalay, and Huseyin Koseoglu, and Ebru Akin, and Aylin Demirezer Bolat, and Naciye Semnur Buyukasik, and Osman Ersoy
August 1987, Southern medical journal,
Tevfik Solakoglu, and Pinar Akyol, and Tekin Guney, and Imdat Dilek, and Roni Atalay, and Huseyin Koseoglu, and Ebru Akin, and Aylin Demirezer Bolat, and Naciye Semnur Buyukasik, and Osman Ersoy
August 1998, Digestive diseases and sciences,
Tevfik Solakoglu, and Pinar Akyol, and Tekin Guney, and Imdat Dilek, and Roni Atalay, and Huseyin Koseoglu, and Ebru Akin, and Aylin Demirezer Bolat, and Naciye Semnur Buyukasik, and Osman Ersoy
January 1996, Nederlands tijdschrift voor geneeskunde,
Copied contents to your clipboard!